HBV replication is significantly reduced by IL-6

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Kuo, Tzer Min ^a,b   Hu, Cheng Po ^c   Chen, Ya Ling ^a   Hong, Ming Hsiang ^a,b   Jeng, King Song ^d   Liang, Chun Chin T ^a   Chen, Mong Liang ^a,e   Chang, Chungming ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CIRCULAR DNA; CORE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 6;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INFORMATION; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS GENOME; VIRUS INFECTION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL CULTURE; GENETICS; HEPATITIS B; METABOLISM; PHYSIOLOGY;

HEPATITIS B VIRUS; MIRIDAE;

CELLS, CULTURED; GENOME, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-6; NUCLEOCAPSID; VIRUS REPLICATION;

EID: 66649135531     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-41     Document Type: Article

References (29)

1. D Ganem RJ Schneider, Field's virology. New York 4 2001
2. Hepatitis B virus biology. C Seeger WS Mason, Microbiol Mol Biol Rev 2000 64 51 68 10704474 10.1128/MMBR.64.1.51-68.2000 (Pubitemid 30143840)
3. Immune responses in hepatitis B virus infection. B Rehermann, Semin Liver Dis 2003 23 21 38 12616448 10.1055/s-2003-37586
4. Immunology of hepatitis B virus and hepatitis C virus infection. B Rehermann M Nascimbeni, Nat Rev Immunol 2005 5 215 229 15738952 10.1038/nri1573
5. Viral clearance without destruction of infected cells during acute HBV infection. LG Guidotti R Rochford J Chung M Shapiro R Purcell FV Chisari, Science 1999 284 825 829 10221919 10.1126/science.284.5415.825
6. Noncytolytic control of viral infections by the innate and adaptive immune response. LG Guidotti FV Chisari, Annu Rev Immunol 2001 19 65 91 11244031 10.1146/annurev.immunol.19.1.65
7. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. VJ Cavanaugh LG Guidotti FV Chisari, J Virol 1997 71 3236 3243 9060687 (Pubitemid 27119971)
8. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. K Kimura K Kakimi S Wieland LG Guidotti FV Chisari, J Virol 2002 76 10702 10707 12368312 10.1128/JVI.76.21.10702-10707.2002
9. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. SF Wieland LG Guidotti FV Chisari, J Virol 2000 74 4165 4173 10756029 10.1128/JVI.74.9.4165- 4173.2000
10. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. SF Wieland A Eustaquio C Whitten-Bauer B Boyd FV Chisari, Proc Natl Acad Sci USA 2005 102 9913 9917 15994231 10.1073/pnas. 0504273102
11. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. R Puro RJ Schneider, J Virol 2007 81 7351 7362 17475655 10.1128/JVI.00554-07
12. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. SJ Lin PY Shu C Chang AK Ng CP Hu, J Immunol 2003 171 4708 4716 14568946 (Pubitemid 37310588)
13. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. YC Chou ML Chen CP Hu YL Chen CL Chong YL Tsai TL Liu KS Jeng C Chang, Hepatology 2007 46 672 681 17580335 10.1002/hep.21726
14. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. T Hirano K Ishihara M Hibi, Oncogene 2000 19 2548 2556 10851053 10.1038/sj.onc.1203551 (Pubitemid 30339210)
15. Interleukin-6: discovery of a pleiotropic cytokine. T Kishimoto, Arthritis Res Ther 2006 8 Suppl 2 S2 16899106 10.1186/ar1916
16. Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease. S Kakumu A Fukatsu T Shinagawa S Kurokawa A Kusakabe, J Clin Pathol 1992 45 408 411 1597519 10.1136/jcp.45.5.408
17. Serum interleukin 6 levels in patients with chronic hepatitis B. S Kakumu T Shinagawa T Ishikawa K Yoshioka T Wakita Y Ito M Takayanagi N Ida, Am J Gastroenterol 1991 86 1804 1808 1962626
18. Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. P Tangkijvanich T Vimolket A Theamboonlers P Kullavanijaya P Suwangool Y Poovorawan, Asian Pac J Allergy Immunol 2000 18 2 109 114 10928624 (Pubitemid 30466006)
19. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. W Zhang B Yue GQ Wang SL Lu, Hepatobiliary Pancreat Dis Int 2002 1 4 577 580 14607690 (Pubitemid 36748246)
20. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. H Song le VQ Binh DN Duy JF Kun TC Bock PG Kremsner AJ Luty, J Clin Virol 2003 28 93 103 12927756 10.1016/S1386-6532(02)00271-8
21. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. WE Naugler T Sakurai S Kim S Maeda K Kim AM Elsharkawy M Karin, Science 2007 317 121 124 17615358 10.1126/science.1140485
22. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. E Galun O Nahor A Eid O Jurim S Rose-John HE Blum O Nussbaum E Ilan N Daudi D Shouval, Virology 2000 270 299 309 10792989 10.1006/viro.2000.0210
23. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. YC Chou KS Jeng ML Chen HH Liu TL Liu YL Chen YC Liu CP Hu C Chang, J Virol 2005 79 1813 1823 15650205 10.1128/JVI.79.3.1813-1823.2005
24. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. M Biermer R Puro RJ Schneider, J Virol 2003 77 4033 4042 12634363 10.1128/JVI.77.7.4033-4042.2003
25. STAT3 induces anti-hepatitis C viral activity in liver cells. H Zhu X Shang N Terada C Liu, Biochem Biophys Res Commun 2004 324 518 528 15474458 10.1016/j.bbrc.2004.09.081
26. Kinetics of the immune response during HBV and HCV infection. A Bertoletti C Ferrari, Hepatology 2003 38 4 13 12829979 10.1053/jhep.2003.50310
27. TNF Activates a Conserved Innate Antiviral Response to HBV that Destabilizes Nucleocapsids and Reduces Nuclear Viral DNA. R Puro RJ Schneider, J Virol 2007 81 14 7351 7362 17475655 10.1128/JVI.00554-07
28. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. J Hu DO Toft C Seeger, EMBO J 1997 16 59 68 9009268 10.1093/emboj/16.1.59
29. Hepatitis B virus replication. J Beck M Nassal, World J Gastroenterol 2007 13 48 64 17206754 (Pubitemid 46165462)